Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Redburn Partners Reinstates Neutral on Omnicom Group

Redburn Partners Reinstates Neutral on Omnicom Group

Redburn Partners analyst Bianca Dallal reinstates Omnicom Group (NYSE:OMC) with a Neutral.

byBenzinga Newsdesk

September 8, 2022

1 minute read

Redburn Partners analyst Bianca Dallal reinstates Omnicom Group (NYSE:OMC) with a Neutral.

Analyst Ratings

Breaking Down Natera: 10 Analysts Share Their Views

By Benzinga Insights

June 3, 3:00 PM

Natera (NASDAQ:NTRA) has been analyzed by 10 analysts in the last three months, revealing a diverse range of…

NTRA

Analyst Ratings

Where Halliburton Stands With Analysts

By Benzinga Insights

April 3, 5:01 PM

Over the past 3 months, 11 analysts have published their opinion on Halliburton (NYSE:HAL) stock. These analysts are…

HAL

Mustang Bio Announces First Patient Successfully Treated By Ex Vivo Lentiviral Gene Therapy To Treat RAG1 Severe Combined Immunodeficiency

By Benzinga Newsdesk

July 27, 8:14 AM

Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for

MBIO

SoftBank’s Vision Fund Business Plans Layoff, In Talks To Get Intel As Key Investor For Arm’s IPO: Report

By Lekha Gupta

June 13, 5:32 AM

SoftBank Group Corp (OTC: SFTBY)(OTC: SFTBY) is reportedly aiming for a fresh round of layoffs at its Vision Fund investment arm.

INTC

Redburn Partners Reinstates Neutral on Omnicom Group

Related Posts

Breaking Down Natera: 10 Analysts Share Their Views

Where Halliburton Stands With Analysts

Mustang Bio Announces First Patient Successfully Treated By Ex Vivo Lentiviral Gene Therapy To Treat RAG1 Severe Combined Immunodeficiency

SoftBank’s Vision Fund Business Plans Layoff, In Talks To Get Intel As Key Investor For Arm’s IPO: Report